Vice President, Clinical Operations
Absci · United States - Remote
Bio & Science AIremoteexecutive$295k–$355k
At a glance
Highlights
- Lead end-to-end sponsor operations for Phase 1/2 and global Phase 3 program.
- Translate clinical strategy into global operational plan for registrational study.
- Advance novel therapeutics built on generative AI drug creation platform.
What they offer
- equity
- bonus
Ideal candidate
Seasoned global clinical operations leader who thrives blending strategy with hands-on execution, driving urgency, accountability and quality to deliver complex late-stage programs.
Requirements
- Substantial experience leading complex global late-stage and registrational programs
- End-to-end Sponsor operational leadership across CROs, vendors, sites and functions
- Comfortable combining strategic leadership with hands-on execution in lean biotech
- Strong cross-functional leadership and ability to influence senior stakeholders
- Excellent executive communication, judgment, problem-solving and decision-making skills
Lab profile
About Absci
Clinical-stage biotech using generative AI and synthetic biology to design novel therapeutics.
What they build
- Integrated Drug Creation platform
- AI-designed novel therapeutics
Known for
- Generative AI models
- Synthetic biology data engine
- Antibody design
Key facts
- Headquartered in Vancouver, WA
- Offices in New York City, Switzerland, and Serbia
- Clinical-stage biotechnology company
Posted · Last seen